No profile icon.   Welcome, Guest [ Sign In ]

Institutional Biosafety Committee (IBC)

In accordance with the National Institutes of Health (NIH) Guidelines, the National Cancer Institute-Frederick (NCI-F) has established an Institutional Biosafety Committee (IBC) . The committee represents the interests of the surrounding community with respect to public health and protection of the environment, animal containment principles and biological safety.

The IBC is responsible for reviewing projects that involve, but are not limited to: rDNA/RNA; RNAi (shRNA/siRNA); Pathogens; Oncogenes; Biological Toxins; Human Materials; Other potentially infectious material (OPIM); Transgenic or Knock-Out/In Animals; Synthetic Biology; Nanotechnology; and Dual Use Materials.

Important Note:

To ensure adequate and timely review, the IBC has implemented registration submission deadlines (see right).

There will be no exceptions to this requirement.

2014 Meeting Dates

  • December 17, 2013
  • January 21
  • February 18
  • March 18
  • April 15
  • May 20
  • June 17
  • July 15
  • August 19
  • September 16
  • October 21
  • November 18
  • December 16

2014 Submission Deadlines

  • November 19, 2013
  • December 17, 2013
  • January 21
  • February 18
  • March 18
  • April 15
  • May 20
  • June 17
  • July 15
  • August 19
  • September 16
  • October 21
  • November 18

All meetings will be held in Building 549 Executive Board Room from 12:00 to 3:00.

Current Topics in Biosafety

New! Synthetic Nucleic Acid Molecules – changes to NIH Guidelines

Investigator Responsibilities under NIH Guidelines

NIH Dual Use Research

Biosecurity News in Brief

Strain database: To determine if a particular mouse strain is registered with the NCI-Frederick IBC, please contact NCI-Frederick IBC, 301-846-1451.